Alan Huang
Consultant / Advisor at Casdin Capital /Private Equity/
Net worth: 1 M $ as of 2024-03-30
Profile
Alan Huang is currently an Advisor at Casdin Capital since 2021.
Prior to this, he was the Chief Scientific Officer at Tango Therapeutics, Inc. from 2018 to 2023.
He worked at Novartis AG as a Senior Director from 2009 to 2015 and at Novartis Institutes of Biomedical Research as a Senior Director & Global Head-Oncology from 2003 to 2016.
He also worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. Additionally, he holds a doctorate degree from the University of South Alabama, which he received in 1998, and an undergraduate degree from Fudan University, which he received in 1993.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
TANGO THERAPEUTICS, INC.
0.13% | 2023-03-31 | 135,887 ( 0.13% ) | 1 M $ | 2024-03-30 |
Alan Huang active positions
Companies | Position | Start |
---|---|---|
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Consultant / Advisor | 2021-02-28 |
Former positions of Alan Huang
Companies | Position | End |
---|---|---|
TANGO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-10-05 |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Corporate Officer/Principal | 2015-12-31 |
Novartis AG /U.S. Biologics Manufacturing Operation/ | Director/Board Member | 2015-12-30 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Alan Huang
University of South Alabama | Doctorate Degree |
Fudan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TANGO THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Finance |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Health Technology |
- Stock Market
- Insiders
- Alan Huang